Celgene Corp. (CELG)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity ▲ Share change % change to portfolio
Q4  2019
≡ David Rolfe - Wedgewood Partners Sell 100.00% 393,967 3.47
≡ David Abrams - Abrams Capital Management Sell 100.00% 6,752,869 18.77
Q3  2019
≡ David Rolfe - Wedgewood Partners Reduce 9.07% 39,293 0.35
Q2  2019
≡ David Rolfe - Wedgewood Partners Reduce 17.50% 91,879 0.72
≡ Prem Watsa - Fairfax Financial Holdings Sell 100.00% 14,500 0.07
≡ Meridian Contrarian Fund Sell 100.00% 70,000 1.18
≡ Bill Miller - Miller Value Partners Sell 100.00% 423,255 1.59
≡ Daniel Loeb - Third Point Sell 100.00% 1,750,000 1.85
≡ Seth Klarman - Baupost Group Sell 100.00% 4,000,000 3.27
Q1  2019
≡ Prem Watsa - Fairfax Financial Holdings Buy 14,500 0.07
≡ Daniel Loeb - Third Point Buy 1,750,000 1.85
≡ Seth Klarman - Baupost Group Buy 4,000,000 3.27
≡ David Abrams - Abrams Capital Management Buy 6,752,869 17.89
≡ Meridian Contrarian Fund Reduce 55.97% 89,000 1.50
≡ Bill Miller - Miller Value Partners Reduce 49.38% 412,940 1.55
≡ David Rolfe - Wedgewood Partners Reduce 19.78% 129,493 0.89
≡ Michael Burry - Scion Asset Management Sell 100.00% 45,000 2.79
Q4  2018
≡ Bill Miller - Miller Value Partners Add 0.51% 4,250 0.01
≡ Meridian Contrarian Fund Add 34.75% 41,000 0.52
≡ David Rolfe - Wedgewood Partners Reduce 13.57% 102,742 0.44
Q3  2018
≡ Bill Miller - Miller Value Partners Add 19.04% 133,040 0.40
≡ Meridian Contrarian Fund Add 34.09% 30,000 0.41
≡ David Rolfe - Wedgewood Partners Reduce 12.36% 106,862 0.48
Q2  2018
≡ Bill Miller - Miller Value Partners Add 68.80% 284,850 0.87
≡ Meridian Contrarian Fund Reduce 50.28% 89,000 1.11
≡ David Rolfe - Wedgewood Partners Reduce 6.52% 60,306 0.24
Q1  2018
≡ Meridian Contrarian Fund Add 14.19% 22,000 0.32
≡ Bill Miller - Miller Value Partners Add 18720.68% 411,855 1.61
≡ David Rolfe - Wedgewood Partners Reduce 3.93% 37,776 0.15
≡ Thomas Russo - Gardner Russo & Quinn Sell 100.00% 500 0.00
Q4  2017
≡ Meridian Contrarian Fund Add 15.67% 21,000 0.36
≡ David Rolfe - Wedgewood Partners Add 42.19% 285,542 1.20
≡ Thomas Russo - Gardner Russo & Quinn Buy 500 0.00
Q3  2017
≡ David Rolfe - Wedgewood Partners Reduce 15.34% 122,626 0.61
≡ Lee Ainslie - Maverick Capital Sell 100.00% 19,150 0.03
Q2  2017
≡ David Rolfe - Wedgewood Partners Add 316.36% 607,402 2.42
≡ Bill Miller - Miller Value Partners Buy 2,200 0.01
≡ Lee Ainslie - Maverick Capital Buy 19,150 0.03
Q1  2017
≡ Meridian Contrarian Fund Add 10.74% 13,000 0.31
≡ David Rolfe - Wedgewood Partners Buy 192,000 0.62
Q4  2016
≡ Meridian Contrarian Fund Reduce 19.87% 30,000 0.67
Q2  2016
≡ Meridian Contrarian Fund Add 36.04% 40,000 0.79
≡ Lee Ainslie - Maverick Capital Sell 100.00% 4,900 0.01
Q1  2016
≡ Meridian Contrarian Fund Add 4.72% 5,000 0.10
≡ Lee Ainslie - Maverick Capital Add 105.88% 2,520 0.01
Q4  2015
≡ Lee Ainslie - Maverick Capital Add 13.88% 290 0.00
≡ Meridian Contrarian Fund Buy 106,000 2.33
Q3  2015
≡ Lee Ainslie - Maverick Capital Reduce 6.28% 140 0.00
Q1  2015
≡ Lee Ainslie - Maverick Capital Buy 2,230 0.00

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.